Data Download Against All Proprties of Epitopes Identified in VLCvirus Respource
The following table provides information on identifed epitopes against all nine major oncogenic lung cancer causing virus species. The identified property is briefly described in the file description section. User can download the entire file by clicking the respective file type in click to download section. The identified epitopes having therapeutic potential against oncogenic lung cancer species. The description of oncogenic viruses as follows-- Abbreviations:- BLV - Bovine Leukemia Virus; HBV - Hepatitis B Virus; HPV - Human Papillioma virus; HTLV - HumanT-cell Leukemia Virus; RSV - Rous Sarcoma Virus; STLV - SimianT-cell Leukemia Virus; EBV - Epstein-Barr Virus; JCV - JC virus & MV - Measles Virus
Download all dataset of VLCvirus resourceFile Description | Best antigenic epitopes | Promiscuous epitopes |
---|---|---|
Nona-mer epitope with T-cell stimulating potential | Click to download | Click to download |
Nona-mer epitope with B-cell stimulating potential | Click to download | Click to download |
Nona-mer epitope with Vaccine Adjuvant potential | Click to download | Click to download |
Nona-mer epitope with MHC-I binding potential | Click to download | Click to download |
Nona-mer epitope with MHC-II potential | Click to download | Click to download |
Nona-mer epitope with MHC-I,II binding potential | Click to download | Click to download |
Nona-mer epitope with B-cell & MHC-I binding potential | Click to download | Click to download |
Nona-mer epitope with B-cell & MHC-II potential | Click to download | Click to download |
Nona-mer epitope with B-cell & MHC-I, II binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell & MHC-I binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell & MHC-II binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell & MHC-I, II binding potential | Click to download | Click to download |
Nona-mer epitope with B-cell, Vaccine Adjuvant & MHC-I binding potential | Click to download | Click to download |
Nona-mer epitope with B-cell, Vaccine Adjuvant & MHC-II binding potential | Click to download | Click to download |
Nona-mer epitope with B-cell, Vaccine Adjuvant & MHC-I, II binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell, Vaccine Adjuvant & MHC-I binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell, Vaccine Adjuvant & MHC-II binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell, Vaccine Adjuvant & MHC-I, II binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell, B-cell, & Vaccine Adjuvant potential | Click to download | Click to download |
Nona-mer epitope with T-cell, B-cell, Vaccine Adjuvant & MHC-I binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell, B-cell, Vaccine Adjuvant & MHC-II binding potential | Click to download | Click to download |
Nona-mer epitope with T-cell, B-cell, Vaccine Adjuvant & MHC-I, II binding potential | Click to download | Click to download |
All nine-mers with promiscuous nature in terms of HLA binding potential | Click to download |